Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion's sulfonylhydrazine prodrug enters phase I evaluation

June 27, 2001

EntreMed and Aventis establish collaborative agreement for phase II prostate cancer trial

June 27, 2001

New GH receptor antagonist may have a role in the management of colon cancer

June 26, 2001

Zycos and Aventis Pasteur extend drug discovery alliance

June 26, 2001

Kosan Biosciences awarded SBIR grant for epothilone development

June 25, 2001

IntraDose plus systemic chemotherapy evaluated in H&N cancer patients

June 22, 2001

Recruitment begins in phase II trial of BBR-3464 for pancreatic cancer

June 22, 2001

Irofulven/gemcitabine combination under evaluation in advanced cancers

June 21, 2001

VEGF inhibitors in the AstraZeneca pipeline

June 21, 2001

Cytotoxic topoisomerase inhibitors identified by Rutgers scientists

June 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...